No Picture
News

Bristol Myers, Charles River join Series A funding for iVexSol

Massachusetts-based iVexSol has secured funding to the tune of $23.8 million in its latest Series A round. The new investors include Bristol Myers Squibb, manufacturer Charles River Laboratories and Asahi Kasei Medical. iVexSol is a manufacturer of lentiviral vectors (LVV), used in making gene therapies, and this latest round of…… Click here to view original post… […]

No Picture
News

BLUE CROSS BLUE SHIELD OF MASSACHUSETTS EXPEDITES ACCESS TO CARE FOR TEXAS MEMBERS AFFECTED BY SEVERE WEATHER

BOSTON, Jan. 27, 2023 /PRNewswire/ — In response to severe weather in Texas, Blue Cross Blue Shield of Massachusetts (Blue Cross) is expediting access to care for members who may be affected. Blue Cross has more than 8,500 members living in areas under states of emergency. The company is… Click here to view original post… […]